1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
Follow HRS-7085 tablets: new trials by email Literature Review of HRS-7085 tablets trials Research Report on HRS-7085 tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis HRS-7085 tablets, Placebo - Moderate to Severe Ulcerative Colitis | Phase 1 | Not yet recruiting | Jiangsu HengRui Medicine Co., Ltd. | 8 | 2026-08-01 | 2026-08-12 |
| A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects HRS-7085 Tablets, HRS-7085 simulant - Inflammatory Bowel Disease | Phase 1 | Unknown | Shandong Suncadia Medicine Co., Ltd. | 70 | 2023-12-01 | 2023-12-19 |
| A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. HRS-7085 tablets, Placebo tablet - Inflammatory Bowel Disease | Phase 1 | Completed | Atridia Pty Ltd. | 16 | 2022-12-05 | 2023-04-21 |
Inflammatory Bowel Diseases (2)
Atridia Pty Ltd. (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Shandong Suncadia Medicine Co., Ltd. (1)
Australia (1) · Moldova (1)